Incyte News, Incyte Quote, INCY Quote

Incyte (NQ:INCY) Delayed: 95.94 -1.39 (1.43%)

Prev. Close

$97.33

Today 6M 1Y 5Y

Open

$96.23

52 Wk High

$118.49

52 Wk Low

$55.00

Day High

$96.30

Day Low

$94.61

P/E

N/A

EPS

$-0.56

Volume

1,255,015

Friends, Peers and Foes (?): LLY, GUD, PFE, ACRV, RLAY (more...)

ALERTS | RSS

Mar 6, 2026 05:04 PM Form 8-K INCYTE CORP For: Feb 27
Mar 6, 2026 04:42 PM Incyte receives European approval for Zynyz anal cancer treatment
Mar 6, 2026 04:42 PM Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)
Mar 2, 2026 05:31 PM Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
Feb 27, 2026 08:13 AM CHMP recommends Eli Lilly's Olumiant for teens with severe hair loss
Feb 27, 2026 08:12 AM Lilly's Olumiant (baricitinib) recommended by CHMP for approval of expanded use in the European Union for adolescents with severe alopecia areata
Feb 23, 2026 04:06 PM Form 4 INCYTE CORP For: Feb 19 Filed by: CAGNONI PABLO J
Feb 19, 2026 05:31 PM Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight
Feb 19, 2026 04:02 PM Form 144 INCYTE CORP Filed by: CAGNONI PABLO J
Feb 18, 2026 03:12 AM Incyte (INCY) PT Raised to $117 at Barclays

Entities mentioned with INCY

View All Entities